Christine Brown

Stories

City of Hope unveils plug-and-play CAR T cells that adapt as tumors mutate

As of September 2026: Co-senior author of the meCAR T study; leading development of the Phase I trials

CAR T cells can cure some blood cancers, but doctors can't adjust them once they're infused. City of Hope researchers just showed a way to keep them programmable, using a molecular docking port that accepts new instructions after the cells are in the body.

Updated Sep 23